Do STAT3 inhibitors have potential in the future for cancer therapy?

被引：193

作者：

Wong, Andrea L. A. ^{[1
,2
,3
]}

Hirpara, Jayshree L. ^{[3
]}

Pervaiz, Shazib ^{[4
,5
]}

Eu, Jie-Qing ^{[3
]}

Sethi, Gautam ^{[6
]}

Goh, Boon-Cher ^{[1
,2
,3
,6
]}

机构：

[1] Natl Univ Hlth Syst, Dept Haematol Oncol, Singapore, Singapore

[2] Natl Univ Hlth Syst, Natl Univ Canc Inst Singapore, Haematol Oncol Res Grp, Level 7,NUHS Tower Block,1E Kent Ridge Rd, Singapore 119228, Singapore

[3] Canc Sci Inst, Singapore, Singapore

[4] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore

[5] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore

[6] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore, Singapore

来源：

EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2017年 / 26卷 / 08期

基金：

英国医学研究理事会;

关键词：

GROWTH-FACTOR RECEPTOR; SIGNAL TRANSDUCER; DRUG-RESISTANCE; JAK INHIBITION; ACTIVATOR; TRANSCRIPTION-3; MUTATIONS; AZD1480; CELLS;

D O I：

10.1080/13543784.2017.1351941

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：883 / 887

页数：5

共 21 条

[1] Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor [J].

Alvarez, JV ;

Greulich, H ;

Sellers, WR ;

Meyerson, M ;

Frank, DA .

CANCER RESEARCH, 2006, 66 (06) :3162-3168

[2] Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factor [J].

Becker, T. M. ;

Boyd, S. C. ;

Mijatov, B. ;

Gowrishankar, K. ;

Snoyman, S. ;

Pupo, G. M. ;

Scolyer, R. A. ;

Mann, G. J. ;

Kefford, R. F. ;

Zhang, X. D. ;

Rizos, H. .

ONCOGENE, 2014, 33 (09) :1158-1166

[3] Targeting transcription factor STAT3 for cancer prevention and therapy [J].

Chai, Edna Zhi Pei ;

Shanmugam, Muthu K. ;

Arfuso, Frank ;

Dharmarajan, Arunasalam ;

Wang, Chao ;

Kumar, Alan Prem ;

Samy, Ramar Perumal ;

Lim, Lina H. K. ;

Wang, Lingzhi ;

Goh, Boon Cher ;

Ahn, Kwang Seok ;

Hui, Kam Man ;

Sethi, Gautam .

PHARMACOLOGY & THERAPEUTICS, 2016, 162 :86-97

[4]

Dimri S, 2017, INTEGR MOL MED, V4, P1

[5] Pharmacological manipulation of transcription factor protein-protein interactions: Opportunities and obstacles [J].

Fontaine F. ;

Overman J. ;

François M. .

Cell Regeneration, 4 (1) :4:2

[6] STAT inhibitors for cancer therapy [J].

Furqan, Muhammad ;

Akinleye, Akintunde ;

Mukhi, Nikhil ;

Mittal, Varun ;

Chen, Yamei ;

Liu, Delong .

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6

[7] Pharmacologic Suppression of JAK1/2 by JAK1/2 Inhibitor AZD1480 Potently Inhibits IL-6-Induced Experimental Prostate Cancer Metastases Formation [J].

Gu, Lei ;

Talati, Pooja ;

Vogiatzi, Paraskevi ;

Romero-Weaver, Ana L. ;

Abdulghani, Junaid ;

Liao, Zhiyong ;

Leiby, Benjamin ;

Hoang, David T. ;

Mirtti, Tuomas ;

Alanen, Kalle ;

Zinda, Michael ;

Huszar, Dennis ;

Nevalainen, Marja T. .

MOLECULAR CANCER THERAPEUTICS, 2014, 13 (05) :1246-1258

[8] JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis [J].

Harrison, Claire ;

Kiladjian, Jean-Jacques ;

Al-Ali, Haifa Kathrin ;

Gisslinger, Heinz ;

Waltzman, Roger ;

Stalbovskaya, Viktoriya ;

McQuitty, Mari ;

Hunter, Deborah S. ;

Levy, Richard ;

Knoops, Laurent ;

Cervantes, Francisco ;

Vannucchi, Alessandro M. ;

Barbui, Tiziano ;

Barosi, Giovanni .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (09) :787-798

[9] AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer [J].

Hong, David ;

Kurzrock, Razelle ;

Kim, Youngsoo ;

Woessner, Richard ;

Younes, Anas ;

Nemunaitis, John ;

Fowler, Nathan ;

Zhou, Tianyuan ;

Schmidt, Joanna ;

Jo, Minji ;

Lee, Samantha J. ;

Yamashita, Mason ;

Hughes, Steven G. ;

Fayad, Luis ;

Piha-Paul, Sarina ;

Nadella, Murali V. P. ;

Mohseni, Morvarid ;

Lawson, Deborah ;

Reimer, Corinne ;

Blakey, David C. ;

Xiao, Xiaokun ;

Hsu, Jeff ;

Revenko, Alexey ;

Monia, Brett P. ;

MacLeod, A. Robert .

SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (314)

[10] Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia [J].

Koskela, Hanna L. M. ;

Eldfors, Samuli ;

Ellonen, Pekka ;

van Adrichem, Arjan J. ;

Kuusanmaki, Heikki ;

Andersson, Emma I. ;

Lagstrom, Sonja ;

Clemente, Michael J. ;

Olson, Thomas ;

Jalkanen, Sari E. ;

Majumder, Muntasir Mamun ;

Almusa, Henrikki ;

Edgren, Henrik ;

Lepisto, Maija ;

Mattila, Pirkko ;

Guinta, Kathryn ;

Koistinen, Pirjo ;

Kuittinen, Taru ;

Penttinen, Kati ;

Parsons, Alun ;

Knowles, Jonathan ;

Saarela, Janna ;

Wennerberg, Krister ;

Kallioniemi, Olli ;

Porkka, Kimmo ;

Loughran, Thomas P., Jr. ;

Heckman, Caroline A. ;

Maciejewski, Jaroslaw P. ;

Mustjoki, Satu .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (20) :1905-1913

← 1 2 3 →